The global wearable injectors market was valued at US$ 5026.20 Million in 2020 and is expected to reach US$ 19523.50 Million by 2030, growing at a CAGR of 15.1% from 2021 – 2028.
Wearable injectors are patches of drug delivery devices utilized in high volume medications such as single-step administration of medicines which are further utilized for longer duration treatment. These are patches pasted temporarily on the skin which results in delivering drugs through tissues in large volumes in the body. The wearable injectors are of two types “in-body” and “off-body” wearable injectors. The best part about these injectors is that they are user-friendly, disposable, cause less pain and discomfort, and are far better than syringes & vials. The best part about these devices is that they deliver the preset doses to the patients at an optimal time and are built-in for single use only. When the dose is complete, very conveniently they are removed from the body and decomposed. Wearable injectors are majorly used in the treatment of cardiovascular diseases, cancer, rheumatoid arthritis, neurological disorder, and chronic diseases such as diabetes hence driving the global wearable injectors market. In this fast-changing era, the use of technology in medical science is growing hence paving pathways for better healthcare facilities globally. For instance, technological advancements such as digital displays and Bluetooth connectivity with smartphones are augmenting the market growth vigorously.
Increase in investments in the healthcare industry, technological advancements in the medical industry, increasing prevalence of chronic diseases, cancer & cardiovascular diseases, hike in the usage of biologics, upsurge in the number of geriatric population, demand for home-based treatment facilities are driving the global wearable injectors market. However, lack of proper treatment facilities and healthcare infrastructure especially in under-developed regions, high costs, and associated side effects are majorly hampering the market growth. Furthermore, the key players are investing in the market and acquiring strategies such as partnerships, collaborations, and product development to provide better opportunities in the market. Additionally, extensive R&D projects supported by various government and corporate sectors are augmenting the market growth and providing lucrative opportunities for the global wearable injectors market.
The global wearable injectors market is fragmented on the basis of Type, Usage, Technology, Mechanism of injection, Therapeutics area, End-User, and Region. Based on Type, the global market is classified into on-body, and off-body. By Type, the on-body segment is leading the market owing to the simplified & convenient usage. Based on Usage, the scope of the report covers disposable and semi-reusable. The semi-reusable segment is leading the market because it produces fewer wastes and it is reusable. Based on Technology, the global market is bifurcated into mechanical injectors, electronic injectors, and others. The mechanical injectors segment dominates the market because it is user-friendly as well as pocket-friendly. By Mechanism of injection, the market is classified into spring-driven, motor-driven, expanding battery, collapsible reservoir, rotary pump, and pressurized gas. By Therapeutic area, the global wearable injectors market is segmented into diabetes, oncology, infectious disease, cardiovascular disease, and autoimmune disorder. Among Therapeutic area segment, diabetes dominates the market owing to high prevalence of the disease globally. Based on End User, the market is classified into clinics, hospitals, home care settings, ambulatory surgery centers, and others. The home care settings segment is leading the market owing to the convenience.
Based on Region, the global wearable injectors market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is further classified into the U.S., Canada, and Mexico. Europe is further segmented into Germany, the U.K., France, Italy, Spain, Russia, and the rest of Europe. Asia-Pacific is segmented into China, Japan, India, Australia, South Korea, and the rest of APAC. The RoW includes South & Central America, the Middle East, and Africa. North America is dominating the global wearable injectors market among all the geographies owing to the presence of active market players, rising chronic ailments, and the presence of advanced healthcare facilities in the region.
Prominent players of the global wearable injectors market are Enable Injections, United Therapeutics (Steadymed Therapeutics, Inc.), Insulet Corporation, Medtronic PLC, Sensile Medical Ag, West Pharmaceutical Services, Inc., Becton Dickinson and Company, Buhler Motor Gmbh, Ypsomed, and Eoflow, among others.
Market Segmentation and Scope of the Global Wearable Injectors Market
By Mechanism of Injection
By Therapeutic area
By End User
Rest of the World